Small cap stocks are largely immune from tariff worries and tend to be bigger beneficiaries of tax cuts than large multi-national companies.
The S&P Small Cap 600 is outperforming large-caps at a three-month premium not seen in more than a decade and a half.
Volatility is back, and chaos has ensued, but the bull market party isn't over yet, says this market expert.
'Pandora's Box has been opened,' says one expert.
Here are the three biggest takeaways from Consensus 2018, the biggest event in blockchain.
The company anticipates its share could begin trading on the NYSE before the end of May.
These three "strong buy" biotech stocks are primed for outsized growth in the next 12 months. Here's why.
Corporate profits are higher and companies are beating earnings expectations and yet the indices basically are flat, so what gives? Real Money columnist Helene Meisler will tell you -- plus give you a much-needed reality check. Listen now!
When a cannabis company needs money to fuel growth, it's never as simple as heading to the bank to shop investors.
From OTC to ADR to Nasdaq: This can be the zig-zagged experience of a cannabis company seeking shareholder stability.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.